(Nasdaq: VCYT), a leading cancer diagnostics company, today announced results from the ENZAMET trial presented at the 2026 ASCO Annual Meeting. The analysis demonstrates that the Decipher Prostate ...

A new Moffitt Cancer Center study suggests a widely used genomic test can more accurately identify which men with early prostate cancer are at high risk for their disease to come back quickly after ...

Upcoming presentations at the ASCO meeting in Chicago highlight potential practice-changing studies in cancer care.

To check for possible prostate cancer, physicians most often use prostate-specific antigen (PSA) tests and digital rectal exams (DREs). For a firm diagnosis, they use core needle biopsies. This page ...

Confused about prostate cancer screening? Discover how the PSA test, modern MRI scans, and early detection can help you make ...

Acupath Laboratories announced today the integration of the ArteraAI Prostate Test into its diagnostic workflows, allowing for fast and convenient delivery of treatment insights. The ArteraAI Prostate ...

At-home cancer tests are a great way to learn key information about your health without having to visit the doctor in person. This option is good for patients who dont have time to go to the doctors ...